MedTech Dive January 7, 2022
Dive Brief:
- Abbott Laboratories is making a play for the consumer wearables market with a line of patches that track the levels of biomarkers such as glucose, ketones and lactate.
- The product line, branded Lingo, builds on Abbott’s successful FreeStyle Libre technology, which diabetics use to monitor their blood glucose. By expanding to other biomarkers, Abbott is aiming to capture a slice of the $13 billion health tracking market.
- Abbott revealed the technology in a Consumer Electronics Show presentation, becoming the first healthcare company to headline the event and giving it a high-profile, 60-minute slot in which to pitch the technology. The company’s push into the consumer space is part of a broader trend in medtech.
Dive Insight:
...Today's Sponsors
Today's Sponsor